"Our next goal is to invest and create our own large animal health products unit and increase capacities at least for a few vaccines in Ahmedabad," Hester Biosciences CEO & Managing Director Rajiv Gandhi said told analysts.
The company plans to invest a little less than Rs 30 crore towards the unit as well as increasing production capacities, he added.
Hester Biosciences has already set up a plant in Nepal which is slated to commence commercial production on November 15, 2016, Gandhi said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
